Zobrazeno 1 - 10
of 211
pro vyhledávání: '"N. N. Volchenko"'
Autor:
M. V. Sedova, M. A. Batov, A. A. Kolomeytseva, V. M. Khomyakov, N. N. Volchenko, A. A. Fedenko
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 10, Iss 3, Pp 8-20 (2023)
Purpose. To study the efficacy and safety of total neoadjuvant chemotherapy (NACT) with the FOLFIRINOX regimen for locally advanced gastric (GC) and cardioesophageal junction (CEJ) cancer.Patients and methods. Patients with histologically confirmed
Externí odkaz:
https://doaj.org/article/932b2c3822704e52941228d798752a98
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 10, Iss 2, Pp 94-103 (2023)
The treatment strategy for Paget’s breast cancer (PBC), as for other morphological forms, is determined by the spread of the invasive tumor process, as well as the absence or presence of adverse factors. Significant prognostic factors, e.g. the inv
Externí odkaz:
https://doaj.org/article/98a1a98b92f244bbb8df2983402d5bc5
Autor:
A. K. Kamalov, A. B. Ryabov, V. M. Khomyakov, N. N. Volchenko, I. V. Kolobaev, A. K. Kostrygin, D. D. Sobolev, A. B. Utkina, S. A. Aksenov, M. P. Makurina
Publikováno v:
Сибирский онкологический журнал, Vol 21, Iss 6, Pp 170-176 (2023)
The purpose of the study. Mesenchymal tumors of the esophagus comprise 2 % of all esophageal tumors. Leiomyosarcoma is the most common mesenchymal tumor in the esophagus (up to 80 %). It is located in the lower third of the esophagus. The main treatm
Externí odkaz:
https://doaj.org/article/ad4bd8c2bbba49d886949efd9e7295bd
Autor:
V. S. Surkova, N. N. Volchenko, E. A. Nikitina, E. A. Troshenkov, A. M. Lavrova, G. G. Khakimova
Publikováno v:
Опухоли женской репродуктивной системы, Vol 18, Iss 3, Pp 71-77 (2022)
Alveolar rhabdomyosarcoma is one of the four subtypes of rhabdomyosarcoma identified by the World Health Organization. This type of malignant neoplasms more often affects deep soft tissues of extremities and occurs in young ages, regardless of gender
Externí odkaz:
https://doaj.org/article/a13a530c33cc4271af54d451a20e8fb4
Autor:
M. M. Bobkova, S. V. Semochkin, V. L. Ivanova, O. G. Agafonova, L. A. Antipova, N. N. Volchenko, V. V. Dergacheva, O. D. Zacharov, Yu. A. Kudinov, S. S. Kulikova, Yu. B. Kochkareva, N. A. Lobanova, I. E. Lazarev, E. V. Laricheva, L. A. Magomedova, N. V. Malachova, V. G. Markaryan, L. A. Mucha, S. V. Minenko, T. Yu. Ostrenkova, E. V. Ovanesova, T. N. Perestoronina, M. E. Ribakova, E. A. Samischina, V. V. Ptuschkin
Publikováno v:
Онкогематология, Vol 0, Iss 4, Pp 4-11 (2022)
Analysis of treatment results of 165 primary adult patients with diffuse B large-cells lymphoma (DBLCL) treating in Moscow municipal clinics is presented. Study aimed on analysis of efficacy of various dose intensity chemotherapy schedule according t
Externí odkaz:
https://doaj.org/article/aab1cc29558b433db499301fc239c159
Evolution of drug therapy in patients with resectable gastric and esophageal‑gastric junction cancer
Autor:
M. V. Sedova, M. A. Batov, V. S. Tretyak, A. A. Kolomeytseva, V. M. Khomyakov, N. N. Volchenko, A. A. Fedenko, A. D. Kaprin
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 10, Iss 2 (2023)
Gastric cancer (GC) is the fifth most common malignant neoplasm in the world among all malignant tumors. Currently, the “gold” standard of treatment for patients with non‑metastatic cancer of the stomach and esophageal–gastric junction is sur
Externí odkaz:
https://doaj.org/article/1dc044a732354a2bab18906bddce02c9
Autor:
A. K. Kamalov, A. B. Ryabov, V. M. Khomyakov, N. N. Volchenko, I. V. Kolobaev, A. K. Kostrygin, S. A. Aksenov
Publikováno v:
Сибирский онкологический журнал, Vol 21, Iss 1, Pp 151-156 (2022)
The purpose of the study was to evaluate the efficacy and safety of laparoscopic transgastric resection for mesenchymal tumors of the proximal stomach.Material and Methods. A retrospective-prospective study was carried out. Surgical techniques of lap
Externí odkaz:
https://doaj.org/article/13a852e805c240ff83143f605fa35709
Publikováno v:
Сибирский онкологический журнал, Vol 20, Iss 4, Pp 116-121 (2021)
The purpose of the study was to present the most recent data on the outcomes of breast-conserving surgery after neoadjuvant chemotherapy for breast cancer patients.Material and methods. We analyzed relevant publications available in the pubmed, cochr
Externí odkaz:
https://doaj.org/article/92b4d700e39d4c6b885f0e9d1fa68fc7
Publikováno v:
Опухоли женской репродуктивной системы, Vol 17, Iss 1, Pp 12-19 (2021)
The recurrence rate after organ-sparing surgeries for breast cancer depends on the resection margins: R1 status is associated with a higher risk of recurrence than R0.We analyzed a group of breast cancer patients with an R1 resection margin who under
Externí odkaz:
https://doaj.org/article/58f00f9f784542fd822aa7fd641af3f4
Publikováno v:
Сибирский онкологический журнал, Vol 20, Iss 2, Pp 118-126 (2021)
Background. Neoadjuvant chemotherapy (NACT) is a standard of care for locally advanced breast cancer patients. One of the main advantages of NACT is the reduction of the tumor size and regression of lymph node metastasis.The aim of the study was to a
Externí odkaz:
https://doaj.org/article/e830e501addc496f9aba3f64cc9ade86